What P&G's $3.8 billion Thorne deal says about building a brand worth buying

Procter & Gamble's $3.8 billion acquisition of supplement maker Thorne is being read across the industry less as a category bet than as a valuation signal.

Thorne grew through practitioner and athlete credibility rather than mass advertising, building a base of consumers who treat the label as a proxy for testing rigor. That trust is precisely the asset a consumer-goods giant cannot manufacture on its own timeline, and it is what commanded the premium.

The strategic risk now sits with the buyer. Scaling a credibility brand into mass retail without diluting the reason people paid attention in the first place is the hardest integration problem in consumer packaged goods.

Analysis via Inc., August 13, 2026.